Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3674

Marea heads to Phase 2b after updated biomarker data show CV drug’s promise

$
0
0
Marea Therapeutics said on Wednesday that its lipid-lowering antibody cut both remnant cholesterol levels and remnant triglycerides — both indicators for cardiovascular disease in at-risk patients. The highest dose tested in the Phase 2a trial of ...

Viewing all articles
Browse latest Browse all 3674

Trending Articles